Twist Bioscience Corporation TWST Foreign currency translation gains (losses)
Foreign currency translation gains (losses) at other companies
Other financials
Where this comes from
Reported directly by Twist Bioscience Corporation in its filing.
Tagged under the XBRL concept us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax.
The official record: Twist Bioscience Corporation’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Twist Bioscience Corporation's foreign currency translation gains (losses).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Twist Bioscience Corporation's foreign currency translation gains (losses)?
- Twist Bioscience Corporation (TWST) reported foreign currency translation gains (losses) of $17K in Q1 2026.
- How has Twist Bioscience Corporation's foreign currency translation gains (losses) changed year-over-year?
- Twist Bioscience Corporation's foreign currency translation gains (losses) increased by 168.0% year-over-year, from -$25K to $17K.
- What is the long-term trend for Twist Bioscience Corporation's foreign currency translation gains (losses)?
- Over 3 years (2021 to 2024), Twist Bioscience Corporation's foreign currency translation gains (losses) has grown at a -59.7% compound annual growth rate (CAGR), from $473K to $31K.
- What does foreign currency translation gains (losses) mean?
- This metric measures the gains or losses resulting from the translation of financial statements of foreign subsidiaries from their functional currency into the company's reporting currency. It captures the impact of exchange rate fluctuations on the value of international operations. This figure is critical for understanding the sensitivity of the company's global footprint to currency market volatility.